NCT01658813View on ClinicalTrials.gov

5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Gastrointestinal Cancer MetastaticRenal Cell Cancer MetastaticNon Small Cell Lung Cancer Metastatic
Interventions
DRUG

5-Fluorouracil and Interferon

5-Fluorouracil Interferon-alfa-2b

Trial Locations (1)

85338

Western Regional Medical Center, Inc, Goodyear

All Listed Sponsors
lead

Western Regional Medical Center

OTHER

NCT01658813 - 5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer | Biotech Hunter | Biotech Hunter